Eltek Ltd.NASDAQ: ELTK

Eltek Ltd. Reports Third-Quarter 2026 Results

· Issued by Eltek Ltd. via PR Newswire

Summary by 6ix AI

Eltek Ltd., an Israeli maker of printed circuit boards, reported revenues of $12.0 million for the third quarter ended September 30, 2026, compared to $13.3 million a year earlier. Net loss was $1.2 million, or $0.17 per fully diluted share, compared to a net loss of $0.2 million, or $0.03 per fully diluted share, in the third quarter of 2025.

Key details

  • Third-quarter 2026 gross profit was $0.2 million (2% of revenues), compared to $1.6 million (12% of revenues) a year earlier. Operating loss was $1.6 million, compared to an operating profit of $0.05 million in the third quarter of 2025.
  • EBITDA (earnings before interest, taxes and depreciation, a measure outside standard US accounting rules) was a loss of $1.0 million in the third quarter of 2026, compared to EBITDA of $0.6 million in the third quarter of 2025.
  • For the nine months ended September 30, 2026, revenues were $34.0 million compared to $38.6 million a year earlier, and net loss was $6.8 million, or $1.01 per fully diluted share, compared to net profit of $1.1 million, or $0.17 per fully diluted share.
  • As of September 30, 2026, Eltek had $10.4 million in cash, cash equivalents and short-term bank deposits and no outstanding debt. Net cash provided by operating activities was $0.04 million in the third quarter.
  • During the third quarter, Eltek completed installation of its 39-meter first plating line, a new production line.

What’s still pending

  • Eltek expects to complete the remaining optimization and validation processes for the new plating line and anticipates beginning qualification processes with key customers in early 2027.

6ix AI wrote this summary from the release below and checked it against the release.

PETACH TIKVA, Israel, Nov. 17, 2026 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a leading global manufacturer of high-quality printed circuit boards, today announced its financial results for the quarter ended September 30, 2026.

Third Quarter 2026 Highlights

  • Revenues were $12.0 million
  • Operating loss was $1.6 million
  • Net loss was $1.2 million, or $0.17 per fully diluted share
  • Net cash provided by operating activities amounted to $0.04 million.
  • $10.4 million in cash, cash equivalents and short-term bank deposits and no outstanding debt as of September 30, 2026.

Ron Freund, Chief Executive Officer, stated:

"Our third-quarter 2026 results reflect continued progress in our operational improvement initiatives, with a reduction in the Company's losses compared to the first two quarters of 2026.

During the quarter, we completed the installation of our 39-meter first plating line. Initial results from the trials conducted to date indicate significant improvements in both product quality and operational efficiency. We expect to complete the remaining optimization and validation processes over the coming months and anticipate beginning qualification processes with key customers in early 2027.

We continue to experience sustained demand for our products, supported by ongoing customer activity and new business opportunities. This positive momentum has contributed to an increase in our order backlog for the remainder of 2026 and into 2027.

In parallel, we have implemented tighter production planning and order management practices, with the objective of better aligning production capacity and schedules with customer-requested delivery dates, while maintaining operational discipline and improving execution.

We remain focused on executing our operational improvement plan, strengthening manufacturing stability, improving production efficiency, and enhancing customer satisfaction through transparency, open communication and a continued commitment to meeting our customers' expectations. These efforts are aimed at positioning Eltek to better capitalize on market demand and future growth opportunities."

Third Quarter 2026 GAAP Financial Results

Revenues for the third quarter of 2026 were $12.0 million compared to $13.3 million in the third quarter of 2025.

Gross profit for the third quarter of 2026 was $0.2 million (2% of revenues) compared to gross profit of $1.6 million (12% of revenues) in the third quarter of 2025.

Operating loss for the third quarter of 2026 was $1.6 million compared to operating profit of $0.05 million in the third quarter of 2025.

Financial income for the third quarter of 2026 was $0.3 million compared to financial expenses of $0.3 million in the third quarter of 2025. Financial income primarily resulted from the erosion of the NIS against the U.S. Dollar.

Net loss for the third quarter of 2026 was $1.2 million, or $0.17 per fully diluted share, compared to a net loss of $0.2 million, or $0.03 per fully diluted share, in the third quarter of 2025.

As of September 30, 2026, we had $10.4 million in cash, cash equivalents and short-term bank deposits and no outstanding debt.

Third Quarter 2026 Non-GAAP Financial Results

EBITDA loss for the third quarter of 2026 was $1.0 million compared to EBITDA of $0.6 million in the third quarter of 2025.

Nine Months Ended September 30, 2026 GAAP Financial Results

Revenues for the first nine months of 2026 were $34.0 million compared to $38.6 million in the first nine months of 2025.

Gross loss for the first nine months of 2026 was $2.6 million compared to gross profit of $6.8 million (18% of revenues) in the first nine months of 2025.

Operating loss for the first nine months of 2026 was $7.4 million compared to operating profit of $2.2 million in the first nine months of 2025.

Financial expenses for the first nine months of 2026 were $0.5 million compared to $0.8 million in the first nine months of 2025. Financial expenses primarily resulted from the erosion of the U.S. Dollar against the NIS.

Net loss for the first nine months of 2026 was $6.8 million, or $1.01 per fully diluted share, compared to net profit of $1.1 million, or $0.17 per fully diluted share, in the first nine months of 2025.

Nine Months Ended September 30, 2026 Non-GAAP Financial Results

EBITDA loss for the first nine months of 2026 was $5.6 million compared to EBITDA of $3.8 million in the first nine months of 2025.

About our Non-GAAP Financial Information

The Company reports financial results in accordance with U.S. GAAP and herein provides EBITDA, a non-GAAP measure. This non-GAAP measure is not in accordance with, nor is it a substitute for, GAAP measures. This non-GAAP measure is intended to supplement the Company's presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measure presented to evaluate and manage the Company's operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in a table below.

Conference Call

Today, Tuesday, November 17, 2026, at 8:30am Eastern Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Ron Freund, Chief Executive Officer.

To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:

United States:     1-866-860-9642
Israel:                  03-918-0691
International:       +972-3-918-0691

To Access a Replay of the Call

A replay of the call will be available for 30 days on the Investor Info section on Eltek's corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.

About Eltek

Eltek – "Innovation Across the Board" – is a leading Israeli manufacturer of advanced printed circuit boards (PCBs), serving customers worldwide in demanding, technology-driven industries. Founded in 1970, the Company specializes in the design and manufacture of complex, high-reliability PCBs, including HDI, multilayer, rigid-flex and flexible boards, for mission-critical applications. Eltek serves leading customers in the defense, aerospace, medical and other advanced industries across Israel, North America, Europe and Asia. The Company combines advanced manufacturing capabilities, engineering expertise and internationally recognized quality standards, including AS9100D and NADCAP Electronics, to deliver high-performance solutions where quality and reliability are essential. Eltek is ITAR compliant.

Headquartered in Israel, Eltek operates advanced manufacturing and R&D facilities in Israel, a marketing subsidiary in North America and an international network of sales representatives and distributors. For more information, visit Eltek's web site at www.nisteceltek.com

Forward Looking Statement

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, changes in general economic, market and business conditions,  the impact of currency movements between the US Dollar exchange rate against the Israeli Shekel, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, the sales cycle, risks associated with Eltek's international operations and its location in Israel, including those arising from regional military conflicts and geopolitical instability,  and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

Investor Contact

Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023

Eltek Ltd.

Consolidated Statements of Income

U.S dollars in thousands (except per share data)

Three months ended

Nine months ended

September 30,

September 30,

2026

2025

2026

2025

Revenues

12,019

13,267

33,989

38,552

Costs of revenues

(11,789)

(11,671)

(36,575)

(31,725)

Gross profit (loss)

230

1,596

(2,586)

6,827

Research and development expenses, net

-

-

-

(50)

Selling, general and administrative expenses

(1,854)

(1,546)

(4,851)

(4,546)

Operating income (loss)

(1,624)

50

(7,437)

2,231

Financial income (expenses), net

295

(287)

(497)

(795)

Income (loss) before income tax

(1,329)

(237)

(7,934)

1,436

Income tax expenses (tax benefit)

(172)

(6)

(1,180)

300

Net income (loss)

(1,157)

(231)

(6,754)

1,136

Earnings per share:

Basic net income (loss) per ordinary share

(0.17)

(0.03)

(1.01)

0.17

Diluted net income (loss) per ordinary share

(0.17)

(0.03)

(1.01)

0.17

Weighted average number of ordinary shares used to compute

basic net income (loss) per ordinary share (in thousands)

6,721

6,719

6,720

6,716

Weighted average number of ordinary shares used to compute

diluted net income (loss) per ordinary share (in thousands)

6,783

6,796

6,785

6,789

Eltek Ltd.

Consolidated Balance Sheets

U.S dollars in thousands

September 30,

December 31,

2026

2025

Assets

Current assets:

Cash and cash equivalents

9,131

2,481

Short-term bank deposits

1,248

9,643

Trade receivables (net of allowance for credit losses)

10,761

14,789

Inventories

10,197

11,154

Other accounts receivable and prepaid expenses

595

607

Total current assets

31,932

38,674

Long term assets:

Severance pay fund

74

65

Deferred tax assets, net

1,664

387

Operating lease right of use assets

12,102

6,272

Total long term assets

13,840

6,724

Property and equipment, net

24,099

20,862

Total Assets

69,871

66,260

Liabilities and Shareholder's equity

Current liabilities:

Trade payables

7,393

6,047

Other accounts payable and accrued expenses

6,825

6,565

Short-term operating lease liabilities

942

1,100

Total current liabilities

15,160

13,712

Long-term liabilities:

Accrued severance pay

824

515

Long-term operating lease liabilities

11,761

5,296

Total long-term liabilities

12,585

5,811

Shareholders' equity:

Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at 
September 30, 2026 and December 31, 2025; Issued and outstanding: 
6,722,393 shares at September 30, 2026 and 6,719,827 shares at
December 31, 2025

6,014

6,012

Foreign currency translation adjustments

7,877

6,111

Additional paid-in capital

36,056

35,681

Accumulated deficit

(7,821)

(1,067)

Total shareholders' equity

42,126

46,737

Total liabilities and shareholders' equity

69,871

66,260

Eltek Ltd.

Unaudited Non-GAAP EBITDA Reconciliations

U.S dollars in thousands

Three months ended

Nine months ended

September 30,

September 30,

2026

2025

2026

2025

GAAP net income (loss)

(1,157)

(231)

(6,754)

1,136

Add back items:

Financial income (expenses), net

295

(287)

(497)

(795)

Income tax expenses (tax benefit)

(172)

(6)

(1,180)

300

Depreciation

626

563

1,829

1,530

Non-GAAP EBITDA

(998)

613

(5,608)

3,761

Eltek Ltd.

Consolidated Statement of  Cash flow

U.S dollars in thousands

Three months ended

Nine months ended

September 30,

September 30,

2026

2025

2026

2025

Cash flows from operating activities:

Net Income (loss)

(1,157)

(231)

(6,754)

1,136

Adjustments to reconcile net income to net cash flows

provided by operating activities:

Depreciation

626

563

1,829

1,530

Unrealized financing expenses (income), net

55

11

(100)

477

Share-based compensation

119

131

361

401

Decrease (increase) in deferred tax assets

(211)

27

(1,275)

229

589

732

815

2,637

Decrease (increase) in operating lease right-of-use assets

166

19

477

19

Decrease (increase) in trade receivables

603

626

4,691

(1,107)

Decrease (increase) in other receivables and prepaid expenses

350

(10)

38

237

Decrease (increase) in inventories

(179)

857

1,435

(1,755)

Increase (decrease) in trade payables

(871)

(137)

(642)

(2,137)

Increase (decrease) in other liabilities and accrued expenses

278

127

(12)

99

Increase (decrease)  in employee severance benefits, net

265

19

285

65

612

1,501

6,272

(4,579)

Net cash provided by (used in) operating activities

44

2,002

333

(806)

Cash flows from investing activities:

Purchase of fixed assets

(750)

(1,386)

(2,423)

(4,266)

Withdrawal of (investment in) short-term bank deposits, net

838

-

8,458

534

Net cash provided by (used in) investing activities

88

(1,386)

6,035

(3,732)

Cash flows from financing activities:

Exercise of options

11

28

16

36

Dividend distribution

-

-

-

(1,276)

Issuance of shares, net

-

-

-

-

Net cash provided by (used in) financing activities

11

28

16

(1,240)

Effect of translation adjustments

(402)

(290)

266

327

Net increase (decrease) in cash and cash equivalents

(259)

354

6,650

(5,451)

Cash and cash equivalents at the beginning of the period

9,390

1,770

2,481

7,575

Cash and cash equivalents at the end of the period

9,131

2,124

9,131

2,124

SOURCE Eltek Ltd.

View original source (PR Newswire)Eltek Ltd. on 6ix

Story so far

Earlier from Eltek

All Eltek news releases